A Phase II Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles In Patients With Castration-Resistant Prostate Cancer (MEL-CAP)
Clinical trial NCT01907009 · TERMINATED
Trial details
- NCT number
- NCT01907009
- Sponsor
- Barts & The London NHS Trust
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2016-12-22
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.